Brief: Polypeptide Group Cuts 2022 Guidance
Dec 2 (Reuters) - POLYPEPTIDE GROUP AG PPGN.S :
* GUIDANCE FOR 2022 LOWERED TO REVENUE OF AROUND EUR 285
MILLION
AND AN ADJUSTED EBITDA MARGIN OF AROUND 15%
* JENS FRICKE APPOINTED AS GLOBAL DIRECTOR OPERATIONS AND
MEMBER
OF EXECUTIVE COMMITTEE
* SEVERAL OPERATIONAL ISSUES HAVING AN ADVERSE IMPACT ON
REVENUE
AND PROFITABILITY
Source text for Eikon: ID:nEQ1LFnjHa
Further company coverage: PPGN.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on PolyPeptide AG
See all newsBrief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Brief: Polypeptide Group Provisional Interim Result Of The Public Tender Offer Of Samsung Biologics Co
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Samsung Biologics to launch takeover bid for PolyPeptide in September (updated)